Clinical trials
Observational Spondylosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
34 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2012 | 2 |
| 2014 | 3 |
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
| Unknown status | 7 |
| Recruiting | 4 |
| Terminated | 2 |
| Enrolling by invitation | 2 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mazor Robotics | 2 |
| Peking University People's Hospital | 2 |
| Peking University Third Hospital | 2 |
| Washington University School of Medicine | 2 |
| AOSpine North America Research Network | 1 |
| Aesculap AG | 1 |
| Allina Health System | 1 |
| American British Cowdray Medical Center | 1 |
| Bergman Clinics | 1 |
| Cairo University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Spondylosis | 34 |
| Spondylolisthesis | 7 |
| Intervertebral Disc Degeneration | 6 |
| Radiculopathy | 5 |
| Spinal Cord Compression | 4 |
| Spinal Cord Diseases | 4 |
| Spinal Stenosis | 4 |
| Intervertebral Disc Displacement | 3 |
| Low Back Pain | 3 |
| Neck Pain | 2 |
Trials
Showing 26 to 34 of 34. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.